Séverine Blesson - Concepedia

Author

Séverine Blesson

Drugs for Neglected Diseases Initiative ORCID

Also Known As

Blesson, Severine, Blesson, Séverine, S Blesson, S. Blesson, Severine Blesson, Séverine Blesson, Sévrine Blesson, The KIDS-ART-LINC Collaboration, severine blesson

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Drugs for Neglected Diseases Initiative University of Gondar Addis Ababa University Swiss Tropical and Public Health Institute Institut Gustave Roussy

About

Séverine Blesson is an author at Drugs for Neglected Diseases Initiative specializing in medicine, immunology, and parasitology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	362
2	Education	1	1	11
3	Public Health	1	1	11
4	Allergy	1	1	19
5	Cell Biology	1	1	37

Séverine Blesson

Publications

816

Citations

H-Index

Page 1

	Year	Citations
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, The Lancet Parasitic ProtozoaAfrican TrypanosomiasisPathogenesisPathologyNon-inferiority Trial	2017	265
Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies Antoine Tarral, Séverine Blesson, Olaf Valverde Mordt, Clinical Pharmacokinetics	2014	96
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia Ermias Diro, Séverine Blesson, Tansy Edwards, PLoS neglected tropical diseases	2019	80
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, The Lancet Global Health	2021	55
In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness Caecilia Schmid, Andrea Kuemmerle, Johannes Blum, PLoS neglected tropical diseases	2012	47
Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia Ermias Diro, Tansy Edwards, Koert Ritmeijer, PLoS neglected tropical diseases	2019	42
Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO Séverine Blesson, Jérôme Thiery, Catherine Gaudin, International Immunology InflammationAutoimmune DiseaseT-regulatory CellImmune RegulationImmunology	2002	37
Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction. Carine Asselin‐Paturel, Sma�l Megherat, Isabelle Vergnon, PubMed	2001	32
Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study Andrea Kuemmerle, Caecilia Schmid, Sonja Bernhard, PLoS neglected tropical diseases SleepSleep DisorderClinical Infectious DiseaseNect UseField Study	2021	30
Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study Antoine Tarral, Lionel Hovsepian, Thierry Duvauchelle, Clinical Pharmacokinetics	2023	28

Page 1